FDA — authorised 23 June 2017
- Application: NDA208383
- Marketing authorisation holder: PORTOLA PHARMS INC
- Local brand name: BEVYXXA
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Bevyxxa in United States
FDA authorised Bevyxxa on 23 June 2017
Marketing authorisations
FDA
- Status: approved
Bevyxxa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Bevyxxa approved in United States?
Yes. FDA authorised it on 23 June 2017; FDA has authorised it.
Who is the marketing authorisation holder for Bevyxxa in United States?
PORTOLA PHARMS INC holds the US marketing authorisation.